Filing Details
- Accession Number:
- 0000899243-19-013799
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-16 17:38:55
- Reporting Period:
- 2019-05-14
- Accepted Time:
- 2019-05-16 17:38:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1160308 | Savara Inc | SVRA | Pharmaceutical Preparations (2834) | 841318182 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1307632 | J Richard Hawkins | 6836 Bee Cave Road, Building Iii Suite 200 Austin TX 78746 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-05-14 | 21,682 | $0.52 | 21,682 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-05-14 | 586 | $0.52 | 22,268 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-05-14 | 2,288 | $0.52 | 24,556 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-05-14 | 444 | $0.55 | 25,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-05-14 | 14,591 | $11.07 | 10,409 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-05-15 | 10,409 | $11.16 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-05-14 | 21,682 | $0.00 | 21,682 | $0.52 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-05-14 | 586 | $0.00 | 586 | $0.52 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-05-14 | 2,288 | $0.00 | 2,288 | $0.52 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-05-14 | 444 | $0.00 | 444 | $0.55 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2020-10-22 | No | 4 | M | Direct | |
| 0 | 2020-12-17 | No | 4 | M | Direct | |
| 0 | 2021-08-30 | No | 4 | M | Direct | |
| 728 | 2021-12-16 | No | 4 | M | Direct |
Footnotes
- The price is a weighted average sale price. The sale prices ranged from $10.97 to $11.16. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- The price is a weighted average sale price. The sale prices ranged from $10.99 to $11.31. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- 5,420 of the shares subject to the option vested and became exercisable on October 22, 2010, and the remaining shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on January 22, 2011.
- The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on March 17, 2011.
- The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on November 18, 2011.
- The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on March 16, 2012.
Billionaire Hedge Funds
